Cat.#: ACPP-1184
| Despition | MSX1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1398 | Rat TIMP1 Protein (AC1398) | 2 µg | inquiry |
| ACPP-1113 | Native Porcine GFAP Protein (AC1113) | 25 µl | inquiry |
| ACPP-1115 | Recombinant Human CD45 Protein (6×His Tag) (AC1115) | 50 µg | inquiry |
| ACPP-1541 | Human OTOR Protein (AC1541) | 5 µg | inquiry |
| ACPP-1510 | Human TIMP1 Protein, Sf9 (AC1510) | 2 µg | inquiry |
| ACPP-1602 | Human AKR7A2 Protein (AC1602) | 5 µg | inquiry |
| ACPP-1200 | PAX8 Blocking Peptide (AC1200) | 250 µg | inquiry |
| ACPP-1533 | Human NREP Protein (AC1533) | 2 µg | inquiry |
| ACPP-1836 | Human CHGA Protein (AC1836) | 5 µg | inquiry |
| ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.